Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -11.20%174.13M | -10.68%187.74M | 3.78%190.07M | 21.70%795.38M | 16.11%205.94M | 18.29%196.09M | 33.41%210.2M | 19.84%183.15M | -18.59%653.53M | 3.15%177.36M |
| Cost of revenue | -12.68%146.7M | -9.83%160.89M | 3.85%159.99M | 21.12%668.75M | 14.70%168.22M | 19.90%168.01M | 31.55%178.44M | 18.77%154.06M | -19.87%552.15M | -1.30%146.66M |
| Gross profit | -2.31%27.43M | -15.46%26.85M | 3.40%30.08M | 24.90%126.63M | 22.87%37.72M | 9.49%28.08M | 44.87%31.76M | 25.84%29.09M | -10.83%101.38M | 31.42%30.7M |
| Operating expense | -29.80%11.53M | 18.74%12.48M | 22.85%12.33M | 8.01%44.2M | -38.32%7.03M | 44.73%16.42M | 32.36%10.51M | -2.03%10.04M | -2.04%40.93M | -35.95%11.39M |
| Selling and administrative expenses | -28.63%11.49M | 23.49%13.72M | 10.38%12.14M | 15.77%49.22M | -2.92%11.02M | 48.71%16.1M | 15.61%11.11M | 2.41%10.99M | -5.36%42.52M | -10.82%11.35M |
| -Selling and marketing expense | -10.30%2.32M | 2.12%2.63M | 2.64%2.31M | 7.52%9.93M | -1.52%2.52M | 11.95%2.59M | 11.37%2.57M | 9.27%2.25M | -18.76%9.24M | -5.64%2.55M |
| -General and administrative expense | -32.14%9.17M | 29.93%11.09M | 12.38%9.82M | 18.07%39.29M | -3.32%8.5M | 58.69%13.51M | 16.95%8.54M | 0.78%8.74M | -0.81%33.28M | -12.22%8.79M |
| Other operating expenses | -3.31%1.56M | 0.63%1.66M | 4.88%1.64M | 1.01%6.42M | 1.29%1.6M | 0.73%1.61M | 1.94%1.65M | 0.04%1.56M | 1.14%6.36M | -0.26%1.58M |
| Total other operating income | 18.09%1.52M | 28.93%2.9M | -42.72%1.44M | 43.92%11.44M | 263.95%5.59M | 19.27%1.29M | -31.63%2.25M | 22.82%2.52M | -15.73%7.95M | 144.18%1.54M |
| Operating profit | 36.43%15.9M | -32.38%14.37M | -6.85%17.75M | 36.33%82.42M | 58.98%30.69M | -18.48%11.65M | 51.98%21.25M | 48.04%19.05M | -15.94%60.46M | 246.42%19.31M |
| Net non-operating interest income (expenses) | 16.39%-584.5K | -9.50%-795.96K | -53.39%-873.78K | -7.15%-2.77M | -19.02%-776.72K | -8.74%-699.11K | -16.54%-726.9K | 14.74%-569.65K | 2.28%-2.59M | -3.42%-652.61K |
| Non-operating interest expense | -16.39%584.5K | 9.50%795.96K | 53.39%873.78K | 7.15%2.77M | 19.02%776.72K | 8.74%699.11K | 16.54%726.9K | -14.74%569.65K | -2.28%2.59M | 3.42%652.61K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 0 | 0 | 132.40%45.78K | 132.40%45.78K | 0 | 0 | 0 | 78.45%-141.3K | 72.81%-141.3K |
| Less:Write off | --0 | --0 | --0 | -132.40%-45.78K | -132.40%-45.78K | --0 | --0 | --0 | -78.45%141.3K | -72.81%141.3K |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 39.80%15.31M | -33.87%13.57M | -8.70%16.87M | 38.05%79.69M | 61.85%29.96M | -19.77%10.95M | 53.63%20.53M | 51.47%18.48M | -15.87%57.73M | 318.60%18.51M |
| Income tax | 35.23%3.87M | -29.32%3.49M | -1.94%4.43M | 45.50%20.68M | 74.28%8.4M | -11.72%2.86M | 55.66%4.94M | 51.43%4.51M | -17.90%14.21M | 138.61%4.82M |
| Net income | 41.42%11.45M | -35.31%10.08M | -10.89%12.45M | 35.62%59.01M | 57.47%21.56M | -22.27%8.09M | 53.00%15.59M | 51.49%13.97M | -15.18%43.51M | 469.99%13.69M |
| Net income continuous operations | 41.42%11.45M | -35.31%10.08M | -10.89%12.45M | 35.62%59.01M | 57.47%21.56M | -22.27%8.09M | 53.00%15.59M | 51.49%13.97M | -15.18%43.51M | 469.99%13.69M |
| Noncontrolling interests | 12.65%1.6M | -64.77%1.19M | -21.90%1.88M | 70.67%11.01M | 45.01%3.79M | 6.05%1.42M | 338.24%3.39M | 39.86%2.41M | 14.75%6.45M | 3,701.30%2.62M |
| Net income attributable to the company | 47.56%9.84M | -27.13%8.89M | -8.60%10.57M | 29.52%48M | 60.41%17.77M | -26.46%6.67M | 29.59%12.2M | 54.16%11.56M | -18.87%37.06M | 347.52%11.08M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 47.56%9.84M | -27.13%8.89M | -8.60%10.57M | 29.52%48M | 60.41%17.77M | -26.46%6.67M | 29.59%12.2M | 54.16%11.56M | -18.87%37.06M | 347.52%11.08M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 48.39%0.0092 | -27.19%0.0083 | -8.33%0.0099 | 29.77%0.0449 | 59.62%0.0166 | -27.06%0.0062 | 29.55%0.0114 | 54.29%0.0108 | -18.97%0.0346 | 352.17%0.0104 |
| Diluted earnings per share | 48.39%0.0092 | -27.19%0.0083 | -8.33%0.0099 | 29.77%0.0449 | 59.62%0.0166 | -27.06%0.0062 | 29.55%0.0114 | 54.29%0.0108 | -18.97%0.0346 | 352.17%0.0104 |
| Dividend per share | -12.50%0.007 | 0 | 25.00%0.01 | 0.00%0.016 | 0 | 33.33%0.008 | 0 | 0.008 | -20.00%0.016 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.